Table 2.

Significant differential expression of the miR 17-92 cluster in MYC amplified AS compared to MYC-unamplified AS, other vascular tumors, well-differentiated liposarcomas (WDLPS) and dedifferentiated liposarcomas (DDLPS)

	Mean clone count		Frequency of cloning (log. scale)
MicroRNA	MYC-amplified AS	MYC unamplified AS	MYC-amplified AS	MYC unamplified AS	FC	FDR
hsa-miR-17-92 cluster	36687	15609	6.54E-02	1.48E-02	4.4	4E-02
hsa-miR-17	12999	5137	2.3E-02	6.7E-03	3.4	1.8E-02
hsa-miR-18a	4160	1334	7.7E-03	1.3E-03	5.7	3.3E-02
hsa-miR-19a	10107	4744	1.9E-02	5.3E-03	3.6	1.2E-01
hsa-miR-20a	9357	4344	1.6E-02	4.2E-03	3.8	3.5E-02
hsa-miR-92a	19	5	3.8E-05	1.3E-05	2.8	4.4E-02
MicroRNA	MYC-amplified AS	Other Vascular Tumors	MYC-amplified AS	Other vascular Tumors	FC	FDR
hsa-miR-17-92 cluster	36687	7908	6.54E-02	6.89E-03	9,5	4.4E-04
hsa-miR-17	12999	2606	2,29E-02	2,32E-03	9,8	1,1E-03
hsa-miR-18a	4160	609	7,68E-03	5,24E-04	14,6	5,8E-04
hsa-miR-19a	10107	2305	1,89E-02	2,01E-03	9,4	2,2E-03
hsa-miR-20a	9357	2326	1,59E-02	1,98E-03	8,0	5,1E-03
MicroRNA	MYC-amplified AS	WDLPS	MYC-amplified AS	WDLPS	FC	FDR
hsa-miR-17-92 cluster	36687	2551	6.54E-02	5.4E-03	12.1	2.2E-07
hsa-miR-17	12999	277	2.3E-02	4.7E-04	48,4	2.8E-12
hsa-miR-18a	4160	158	7.7E-03	2.9E-04	26.3	1.8E-08
hsa-miR-19a	10107	1374	1.9E-02	3.1E-03	6	7.7E-04
hsa-miR-20a	9357	742	1.6E-02	1.5–03	10.8	4.8E-06
hsa-miR-92a	19	0	3.8E-05	0	NA	2.9E-10
MicroRNA	MYC-amplified AS	DDLPS	MYC-amplified AS	DDLPS	FC	FDR
hsa-miR-17-92 cluster	36687	2551	6.54E-02	5.4E-03	12.1	2.2E-07
hsa-miR-17	12999	549	2.3E-02	5.9E-04	39	2.6E-06
hsa-miR-18a	4160	274	7.7E-03	3.3E-04	23.1	5.2E-05
hsa-miR-20a	9357	1444	1.6E-02	1.7E-03	9.4	1.9E-03

FC: fold-change; FDR: false discovery rate